官娟, 陆伟跃, 占昌友. 血浆蛋白对脂质体体内性能的调控J. 药学学报, 2019,54(12): 2240-2250. doi: 10.16438/j.0513-4870.2019-0611
引用本文: 官娟, 陆伟跃, 占昌友. 血浆蛋白对脂质体体内性能的调控J. 药学学报, 2019,54(12): 2240-2250. doi: 10.16438/j.0513-4870.2019-0611
GUAN Juan, LU Wei-yue, ZHAN Chang-you. Plasma proteins regulating in vivo performance of liposomesJ. Acta Pharmaceutica Sinica, 2019,54(12): 2240-2250. doi: 10.16438/j.0513-4870.2019-0611
Citation: GUAN Juan, LU Wei-yue, ZHAN Chang-you. Plasma proteins regulating in vivo performance of liposomesJ. Acta Pharmaceutica Sinica, 2019,54(12): 2240-2250. doi: 10.16438/j.0513-4870.2019-0611

血浆蛋白对脂质体体内性能的调控

Plasma proteins regulating in vivo performance of liposomes

  • 摘要: 脂质体是在临床阶段应用最为广泛的纳米药物载体,进入血循环后迅速吸附血浆蛋白,其表面形成的蛋白冠可直接影响脂质体体内各项性能。深入研究脂质体自身性质、血浆蛋白组分与脂质体体内性能间相互关系,是加速新型脂质体药物临床开发和指导脂质体药物临床合理用药的必经之路。本文分别从影响脂质体蛋白冠的因素、蛋白冠对脂质体体内性能的影响和基于蛋白冠的脂质体药物设计三个方面进行综述,为脂质体药物相关研究提供参考。

     

    Abstract: Liposomes have been widely exploited in clinics. After entry into blood stream, liposomes absorb a large number of plasma proteins to form protein corona, which severely regulates in vivo performance of liposomes. It is of high importance to study the relationships among liposome surface properties, plasma protein components and liposome in vivo performance for clinical translation. In this review, we will summarize the factors affecting liposome protein corona, the effects of protein corona on liposome performance and the rational design of liposomes, aiming to accelerate clinical translation of liposome-based therapeutics.

     

/

返回文章
返回